Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
08/2006
08/31/2006WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ
08/31/2006WO2006090716A1 Novel thiophene compound and process for producing caffenofuran or analogue thereof from the same
08/31/2006WO2006089953A1 Compounds for stabilizing factor vii polypeptide formulations
08/31/2006WO2006060029A3 Insecticidal n-substituted sulfoximines
08/31/2006US20060194869 Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
08/31/2006US20060194825 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006US20060194795 Platelet ADP receptor inhibitors
08/31/2006US20060194772 Triamide-substituted heterobicyclic compounds
08/31/2006US20060194256 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
08/31/2006DE102005009517A1 Catalytic production of optionally substituted (hetero)aromatic nitriles, useful in the synthesis of e.g. agro products, comprises reacting aryl halides in the presence of copper compounds and cyanide donor yellow prussiate of potash
08/31/2006CA2599454A1 Activator for peroxisome proliferator activating receptor d
08/31/2006CA2599301A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor
08/30/2006EP1695972A1 Process for producing 2-acylthiophene compound
08/30/2006EP1694665A2 Substituted thiophenes
08/30/2006EP1694643A1 Carboxamide derivatives
08/30/2006EP1694640A1 Anti-cancer agents
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists
08/30/2006EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
08/30/2006EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
08/30/2006EP1458666B1 Improved aromachemicals
08/30/2006EP1442030B1 Thiopene- amd thiazolesulfonamides as antineoplastic agents
08/30/2006EP1359914B1 Novel therapeutic use of a thienylcyclohexylamine derivative for treating pain
08/30/2006EP1020439B1 Cetp activity inhibitors
08/30/2006CN1826330A Combretastatin derivatives with cytotoxic action
08/30/2006CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use
08/30/2006CN1826316A Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/30/2006CN1272324C Novel herbicides
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/29/2006US7098247 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
08/29/2006US7098241 Thiophene hydroxamic acid derivatives
08/29/2006US7098240 Compounds
08/29/2006US7098212 Piperazine derivatives
08/29/2006US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase
08/29/2006US7097917 Compounds for use in organic EL devices and organic EL devices
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/24/2006WO2006088193A1 Anti-tumor agent
08/24/2006WO2006087169A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
08/24/2006WO2006087166A1 Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
08/24/2006WO2006086921A1 A process for the preparation of clopidogrel
08/24/2006WO2006034491A3 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
08/24/2006US20060189678 4,5-dihydronaphtho[1,2-b]thiophene derivative
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006CA2599046A1 Antitumor agent
08/24/2006CA2596909A1 Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
08/23/2006EP1693370A1 Sulfoxyalkylthiophene compound and process for producing the same
08/23/2006EP1692140A1 Compositions useful as inhibitors of protein kinases
08/23/2006EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1692093A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/23/2006EP1438349B1 Triarylamine containing monomers for optoelectronic devices
08/23/2006EP1290059B1 Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method of manufacturing an electronic device
08/23/2006EP1027328B1 Substituted anilides
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/23/2006CN1821229A Processes for preparing benzo[b]thiophene derivatives
08/23/2006CN1271066C Aromatic dicarboxylic acid derivatives
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094907 N,N-(optionally substituted)dialkylamino phosphines bound to an aromatic carbon are lithiated in ortho-position and the lithiated compounds are further converted to said bidentate ligands; oxidative dimerization; coupling
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094515 Stimulus sensitive compound and stimulus sensitive composition containing the same
08/22/2006US7094365 Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
08/22/2006CA2239568C Improved metal-ligand complex catalyzed processes
08/17/2006WO2006085113A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
08/17/2006WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
08/17/2006WO2006084975A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
08/17/2006WO2006084688A1 HIV protease inhibitors
08/17/2006WO2006084338A1 Novel tubulin polymerisation inhibitors
08/17/2006WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases
08/17/2006WO2006021213A3 Vasopressin v1a antagonists
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006US20060183921 Pharmaceutically active compounds and methods of use
08/17/2006US20060183792 Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulators
08/17/2006US20060183791 Substituted p-diaminobenzene derivatives
08/17/2006US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome
08/17/2006US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group
08/17/2006CA2597447A1 Novel tubulin polymerisation inhibitors
08/17/2006CA2597073A1 Glucagon receptor antagonists, preparation and therapeutic uses
08/17/2006CA2596613A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
08/17/2006CA2594395A1 Hiv protease inhibitors
08/17/2006CA2592320A1 Methods and compositions for treating amyloid-related diseases
08/16/2006EP1690861A2 A process for preparing duloxetine and intermediates for use therein
08/16/2006EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
08/16/2006EP1689744A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid
08/16/2006EP1689716A1 Biaryl sulfonamides and methods for using same
08/16/2006EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
08/16/2006EP1689702A1 Organic compounds
08/16/2006EP1689700A1 Novel salicylic anilides
08/16/2006EP1689699A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor
08/16/2006EP1689380A2 Method for treating adamts-5-associated disease
08/16/2006EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
08/16/2006EP1087941B1 Thiolesters and uses thereof
08/16/2006CN1817869A Process for the industrial synthesis of substitute thiophenecarboxydimethylester and application of the compound
08/16/2006CN1269812C Slfonium salts, methods for their preparation and use thereof as photoinitiators for radiation curable systems
08/16/2006CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders